Jason D. Weber
Affiliations: | Biology & Biomedical Sciences (Molecular Cell Biology) | Washington University, Saint Louis, St. Louis, MO |
Area:
Molecular BiologyGoogle:
"Jason Weber"Children
Sign in to add traineeCorey L. Pelletier | grad student | 2006 | Washington University |
Suzanne N. Brady | grad student | 2007 | Washington University |
Scott R. Manson | grad student | 2007 | Washington University |
Robert A. Niederhoff | grad student | 2007 | Washington University |
Anthony J. Apicelli | grad student | 2009 | Washington University |
Mary E. Olanich | grad student | 2010 | Washington University |
Crystal L. Winkeler | grad student | 2011 | Washington University |
Alexander P. Miceli | grad student | 2012 | Washington University |
Jason T. Forys | grad student | 2013 | Washington University |
Michael J. Kuchenreuther | grad student | 2013 | Washington University |
Katie A. Matatall | grad student | 2013 | Washington University |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Cottrell KA, Ryu S, Pierce JR, et al. (2024) Induction of viral mimicry upon loss of DHX9 and ADAR1 in breast cancer cells. Cancer Research Communications |
Zuo C, Baer JM, Knolhoff BL, et al. (2023) Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy. The Journal of Experimental Medicine. 220 |
Cottrell KA, Ryu S, Torres LS, et al. (2023) Induction of viral mimicry upon loss of DHX9 and ADAR1 in breast cancer cells. Biorxiv : the Preprint Server For Biology |
Kung CP, Weber JD. (2022) It's Getting Complicated-A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy. Frontiers in Cell and Developmental Biology. 10: 818744 |
Cottrell KA, Chiou RC, Weber JD. (2020) Upregulation of 5'-terminal oligopyrimidine mRNA translation upon loss of the ARF tumor suppressor. Scientific Reports. 10: 22276 |
Kung C, Kuzmicki CE, Bross EA, et al. (2020) Abstract P4-08-03: Tumor suppressors p53 and ARF control ADAR1-driven tumorigenicity in triple negative breast cancer Cancer Research. 80 |
Wang J, Feng W, Yuan Z, et al. (2019) DHX33 interacts with AP-2β to regulate Bcl-2 gene expression and promote cancer cell survival. Molecular and Cellular Biology |
Yao CH, Wang R, Wang Y, et al. (2019) Mitochondrial fusion supports increased oxidative phosphorylation during cell proliferation. Elife. 8 |
Kung C, Bross E, Bramel E, et al. (2019) 3174 Tumor suppressors p53 and ARF control oncogenic potential of triple-negative breast cancer cells by regulating RNA editing enzyme ADAR1 Journal of Clinical and Translational Science. 3: 25-26 |
Kung CP, Maggi LB, Weber JD. (2018) The Role of RNA Editing in Cancer Development and Metabolic Disorders. Frontiers in Endocrinology. 9: 762 |